|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 800 Maine AVE SW |
Address2 | Suite 900 |
| City | Washington |
State | DC |
Zip Code | 20024-2002 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 3151-12
|
||||||||
|
6. House ID# 304890000
|
||||||||
| TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Craig Obey |
Date | 10/19/2022 2:39:50 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 2023 Labor HHS Education Appropriations
FY 2023 Veteran's Affairs Appropriations
FY 2023 National Defense Authorization Act
FY 2022 Budget Reconciliation
FY 2023 Continuing Appropriations and Ukraine Supplemental Appropriations Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Craig |
Obey |
|
|
|
Mikael |
Troubh |
|
|
|
Michelle |
Greenhalgh |
|
|
|
Tim |
Clement |
|
|
|
Daniel |
Stanford |
III |
|
|
Leslie |
Samuel |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 432 - Mental Health Access Improvement Act
H.R. 1358 - Mental Health Parity Justice Act of 2021
H.R. 1475/ S. 1795 - Pursuing Equity in Mental Health Act
H.R. 2754 - COVID-19 Long Haulers Act
H.R. 3173 - Improving Seniors Timely Access to Care Act of 2021
H.R. 3467 - Improving Data Collection for Adverse Childhood Experiences (ACES) Act
H.R. 3541 / S. 1810 - Conrad State 30 and Physician Access Reauthorization Act
H.R. 3753/ S. 1962 - Parity Implementation Assistance Act
H.R. 4058 / S. 2061 - Telemental Health Care Access Act
H.R. 4122 / S. 3658 - Resident Education Deferred Interest (REDI) Act
H.R. 4040 - Advancing Telehealth Beyond COVID-19 Act
H.R. 4770 - Evaluating Disparities and Outcomes of Telehealth (EDOT) Act of 2021
H.R. 5218 - Collaborate in an Orderly and Cohesive Manner Act
H.R. 6000 - Cures 2.0 Act
H.R. 7116 - 988 Implementation Act of 2022
H.R. 7180 / S. 4014 - Brycen Gray and Bren Price COVID-19 Cognitive Research Act
H.R. 7232 - 988 and Parity Assistance Act of 2022
H.R. 7254 - Mental Health Justice and Parity Act of 2022
H.R. 7482 / S. 4015 - TREAT Act
H.R. 7649 - To direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes.
H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022
H.R. 7667 - Food and Drug Amendments of 2022
H.R. 8180 - Undertaking Needed Investments in Therapy, Education, and De-Escalation (UNITED) Act of 2022
H.R. 8229 - Telemental Health Parity Act
H.R. 8391 - CONNECT Act
H.R. 8487 - Improving Seniors Timely Access to Care Act of 2022
H.R. 8512 - Behavioral Health Coverage Transparency Act
H.R. 8542 - Mental Health Justice Act of 2022
H.R. 8637/ S. 4003 - Law Enforcement De-Escalation Training Act of 2022
H.R. 8800 - Supporting Medicare Providers Act of 2022
H.R. 8878 - Intensive Outpatient Policy
H.R. 8879 - Inpatient Psychiatric Facility Improvement Act
H.R. 8881 - Mental Health Transparency Act
H.R. 8884 - Medicare Opioid Use Disorder Outreach Act
H.R. 8885 - Better Health Care Directories Act
H.R. 8886 - Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act
H.R. 8889 - RICE (Readable Insurance Coverage Enhancement) Act
H.R. 8890 - Physician Wellness Program Act
H.R. 8891 - No Surprises for Survivors Act
H.R. 8892 - Access to Mental Health Services Act
H.R. 8908 - Fighting Stimulant and other Substance Use Disorders Act
H.R. 8910 - Behavioral Health Integration Awareness Act
H.R. 9201 - Community Mental Wellness and Resilience Act
S. 2086 - RISE from Trauma Act
S. 2938 - Bipartisan Safer Communities Act
S. 3726 - CARE for Long COVID Act
S. 4132 - Womens Health Protection Act
S. 4170 - Mental Health Reform Reauthorization Act of 2022
S. 4306 - Improving Access to Behavioral Health Integration Act
S. 4348 - Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022
S. 4448 - Suicide Prevention Act
S. 4461 - Expanding Access to Mental Health Training Act
S. 4472 - Health Care Capacity for Pediatric Behavioral Health Act
S. 4804 - Parity Enforcement Act of 2022
S. 4839 - State Opioid Response Grant Authorization Act
S.5041 - A bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions in psychiatry and subspecialties
S.5042 - A bill to amend title XVIII of the Social Security Act to expand eligibility for incentives under the Medicare health professional shortage area bonus program to practitioners furnishing mental health and substance use disorder services
S.5043 - A bill to require the Secretary of Health and Human Services to issue guidance to States on strategies under Medicaid and CHIP to increase mental health and substance use disorder care provider education, training, recruitment, and retention
S.5061 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage and coding for qualified psychologist services furnished by advanced psychology trainees
S.5062 - A bill to amend title XVIII of the Social Security Act to increase access to mental health programs for physicians
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Samuel |
|
|
|
Mikael |
Troubh |
|
|
|
Craig |
Obey |
|
|
|
Michelle |
Greenhalgh |
|
|
|
Tim |
Clement |
|
|
|
Daniel |
Stanford |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 5721 - VA Infrastructure Powers Exceptional Research (VIPER) Act of 2021
H.R.6273 - VA Zero Suicide Demonstration Project Act of 2021
H.R. 6411 - STRONG Veterans Act
H.R. 7414 - Recruiting in Underserved Rural Areas and Localities for Veterans Act
S. 4156 - VA Workforce Improvement, Support, and Expansion (WISE) Act of 2022
S. 4388 - Military Families Mental Health Services Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Daniel |
Stanford |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |